Er is iets misgegaan bij het laden van deze pagina.
Ons team heeft al een melding ontvangen, maar neem vooral contact op via de widget e-mailondersteuning als het probleem aanhoudt.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | Yes | No |
Is net profit margin increasing? | Yes | Yes |
Is asset turnover increasing? | Yes | No |
Is equity multiplier increasing? | Yes | No |
Competitors Used |
---|
WooGene B&G Co., Ltd |
Yuyu Pharma, Inc. |
JW Shinyak Corporation |
GL Pharm Tech Corp. |
Kyung Nam Pharm Co.,Ltd. |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
A018620 | A000220 | A067290 | A204840 | A053950 | A012790 | |||
Return On Equity | ||||||||
Latest Twelve Months | 4% | 8% | 23% | -15% | -3% | 10% | ||
Fiscal Year - 1 | 3% | -6% | -103% | -26% | -10% | 11% | ||
Fiscal Year - 2 | -7% | -5% | 3% | -5% | -9% | 10% | ||
Fiscal Year - 3 | -11% | -2% | 2% | -24% | -5% | 6% | ||
Fiscal Year - 4 | -1% | 1% | -11% | -42% | -9% | 7% | ||
Fiscal Year - 5 | -27% | 5% | 3% | -108% | -10% | 7% | ||
Average | -7% | 0% | -14% | -37% | -8% | 9% | ||
Median | -4% | -1% | 2% | -25% | -9% | 9% | ||
Benchmarks | Ticker | |||||||
WooGene B&G Co., Ltd | KOSDAQ:A018620 | |||||||
Yuyu Pharma, Inc. | KOSE:A000220 | |||||||
JW Shinyak Corporation | KOSDAQ:A067290 | |||||||
GL Pharm Tech Corp. | KOSDAQ:A204840 | |||||||
Kyung Nam Pharm Co.,Ltd. | KOSDAQ:A053950 |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | A018620 | A000220 | A067290 | A204840 | A053950 | A012790 | ||
Latest Fiscal Year | Dec-23 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
LTM Period | Sep-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
Revenues | ||||||||
Latest Twelve Months | 58,640 | 133,147 | 93,014 | 26,048 | 60,792 | 89,440 | ||
Fiscal Year | 57,919 | 133,147 | 93,014 | 26,048 | 60,792 | 89,440 | ||
Fiscal Year - 1 | 43,703 | 137,210 | 104,235 | 26,033 | 59,303 | 89,135 | ||
Fiscal Year - 2 | 39,347 | 138,881 | 102,710 | 16,729 | 59,000 | 80,007 | ||
Fiscal Year - 3 | 39,524 | 115,655 | 100,966 | 12,426 | 64,623 | 61,754 | ||
Fiscal Year - 4 | 29,656 | 98,120 | 103,803 | 11,988 | 70,933 | 61,438 | ||
Fiscal Year - 5 | 28,131 | 90,878 | 102,531 | 10,608 | 44,806 | 60,648 | ||
Net Income | ||||||||
Latest Twelve Months | 1,241 | 8,720 | 5,082 | (2,337) | (2,648) | 14,301 | ||
Fiscal Year | (1,184) | 8,720 | 5,082 | (2,337) | (2,648) | 14,301 | ||
Fiscal Year - 1 | 850 | (7,181) | (37,357) | (3,749) | (8,339) | 13,641 | ||
Fiscal Year - 2 | (2,258) | (6,273) | 1,400 | (790) | (7,828) | 12,157 | ||
Fiscal Year - 3 | (3,030) | (2,499) | 884 | (3,727) | (3,209) | 6,679 | ||
Fiscal Year - 4 | (333) | 999 | (6,446) | (3,356) | (5,135) | 7,544 | ||
Fiscal Year - 5 | (6,632) | 4,437 | 1,442 | (5,515) | (4,546) | 7,257 | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 110,171 | 198,214 | 65,619 | 39,868 | 166,609 | 152,460 | ||
Latest Fiscal Quarter | 122,008 | 207,687 | 63,035 | 42,440 | 166,584 | 165,861 | ||
Fiscal Year | 121,583 | 207,687 | 63,035 | 42,440 | 166,584 | 165,861 | ||
Fiscal Year - 1 | 91,522 | 198,214 | 65,619 | 39,868 | 166,609 | 152,460 | ||
Fiscal Year - 2 | 76,508 | 195,205 | 94,094 | 40,854 | 138,269 | 142,832 | ||
Fiscal Year - 3 | 77,561 | 192,985 | 92,004 | 31,895 | 125,307 | 128,974 | ||
Fiscal Year - 4 | 85,132 | 154,901 | 96,327 | 34,945 | 126,655 | 124,810 | ||
Fiscal Year - 5 | 60,049 | 137,719 | 136,855 | 26,547 | 74,460 | 117,838 | ||
Fiscal Year - 6 | 60,638 | 135,226 | 109,206 | 31,562 | 53,157 | 106,404 | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 34,163 | 109,595 | 16,770 | 12,282 | 79,362 | 134,895 | ||
Latest Fiscal Quarter | 35,027 | 122,639 | 26,900 | 19,668 | 115,223 | 146,506 | ||
Fiscal Year | 33,524 | 122,639 | 26,900 | 19,668 | 115,223 | 146,506 | ||
Fiscal Year - 1 | 35,317 | 109,595 | 16,770 | 12,282 | 79,362 | 134,895 | ||
Fiscal Year - 2 | 31,144 | 114,224 | 55,973 | 16,090 | 93,771 | 123,277 | ||
Fiscal Year - 3 | 29,845 | 121,689 | 55,444 | 16,849 | 72,529 | 113,196 | ||
Fiscal Year - 4 | 27,266 | 113,062 | 56,556 | 13,813 | 57,364 | 107,484 | ||
Fiscal Year - 5 | 26,513 | 87,397 | 66,144 | 2,362 | 61,194 | 101,245 | ||
Fiscal Year - 6 | 23,039 | 84,495 | 33,489 | 7,817 | 28,912 | 95,185 |